INS and Hyperglycemia: Finally, to ensure accurate training and validation of the model, we restricted ourselves to patients that had accurately documented doses of medications such as insulin, given that it was the action, and vasopressors/inotropes, which indicate the risk of disease severity and thus may portend a higher risk of hyperglycemia, in both development and external validation cohorts.